Duquesne Family Office LLC / SPRY
Duquesne Family Office LLC’s Ars Pharmaceuticals Inc Position
Does Duquesne Family Office LLC own Ars Pharmaceuticals Inc (SPRY)? Not currently — the last reported position was 536.9K shares worth $8M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$8M
Q3 2024
Shares
536.9K
% of Portfolio
+0.26%
Quarters Held
1
position exited
Position History SPRY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 536.9K | $8M | +0.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of SPRY.